{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T01:07:20Z","timestamp":1775610440378,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"DOI":"10.1007\/s11096-025-02016-9","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:34:19Z","timestamp":1758720859000},"page":"513-523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of an interpretable machine learning model to predict short-term bleeding risk in patients receiving dual antithrombotic therapy following cardiac surgery"],"prefix":"10.1007","volume":"48","author":[{"given":"Haolong","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason Z","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"18","key":"2016_CR1","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/j.jcin.2020.07.015","volume":"13","author":"F Maisano","year":"2020","unstructured":"Maisano F. Coronary artery and valve disease, a hostile combination. JACC Cardiovasc Interv. 2020;13(18):2146\u20138. https:\/\/doi.org\/10.1016\/j.jcin.2020.07.015.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"2016_CR2","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.athoracsur.2020.03.003","volume":"109","author":"ME Bowdish","year":"2020","unstructured":"Bowdish ME, D\u2019Agostino RS, Thourani VH, et al. The Society of Thoracic Surgeons adult cardiac surgery database: 2020 update on outcomes and research. Ann Thorac Surg. 2020;109(6):1646\u201355. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.03.003.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"2016_CR3","doi-asserted-by":"publisher","first-page":"600S","DOI":"10.1378\/chest.126.3_suppl.600S","volume":"126","author":"PD Stein","year":"2004","unstructured":"Stein PD, Sch\u00fcnemann HJ, Dalen JE, et al. Antithrombotic therapy in patients with Saphenous Vein and Internal Mammary Artery bypass grafts. Chest. 2004;126(3):600S-S608. https:\/\/doi.org\/10.1378\/chest.126.3_suppl.600S.","journal-title":"Chest"},{"issue":"1","key":"2016_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/ejcts\/ezx334","volume":"53","author":"M Valgimigli","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2018;53(1):34\u201378. https:\/\/doi.org\/10.1093\/ejcts\/ezx334.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"16","key":"2016_CR5","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","volume":"380","author":"RD Lopes","year":"2019","unstructured":"Lopes RD, Heizer G, Aronson R, et al. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med. 2019;380(16):1509\u201324. https:\/\/doi.org\/10.1056\/NEJMoa1817083.","journal-title":"N Engl J Med"},{"key":"2016_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijcard.2018.08.019","volume":"273","author":"F Fortuni","year":"2018","unstructured":"Fortuni F, Ferlini M, Leonardi S, et al. Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: a systematic review and meta-analysis. Int J Cardiol. 2018;273:80\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2018.08.019.","journal-title":"Int J Cardiol"},{"issue":"9872","key":"2016_CR7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/s0140-6736(12)62177-1","volume":"381","author":"WJM Dewilde","year":"2013","unstructured":"Dewilde WJM, Oirbans T, Verheugt FWA, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381(9872):1107\u201315. https:\/\/doi.org\/10.1016\/s0140-6736(12)62177-1.","journal-title":"Lancet"},{"issue":"16","key":"2016_CR8","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","volume":"170","author":"ML Hansen","year":"2010","unstructured":"Hansen ML, Sorensen R, Clausen MT, et al. LESS IS MORE risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med. 2010;170(16):1433\u201341. https:\/\/doi.org\/10.1001\/archinternmed.2010.271.","journal-title":"Arch Intern Med"},{"issue":"22","key":"2016_CR9","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.jacc.2008.12.073","volume":"53","author":"BJ Doyle","year":"2009","unstructured":"Doyle BJ, Rihal CS, Gastineau DA, et al. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention implications for contemporary practice. J Am Coll Cardiol. 2009;53(22):2019\u201327. https:\/\/doi.org\/10.1016\/j.jacc.2008.12.073.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2016_CR10","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.amjcard.2008.07.063","volume":"102","author":"P Roy","year":"2008","unstructured":"Roy P, Bonello L, Torguson R, et al. Impact of \u201cnuisance\u201d bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation. Am J Cardiol. 2008;102(12):1614\u20137. https:\/\/doi.org\/10.1016\/j.amjcard.2008.07.063.","journal-title":"Am J Cardiol"},{"key":"2016_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2023.11.034","author":"A Abbasi","year":"2023","unstructured":"Abbasi A, Li C, Dekle M, et al. Interpretable machine learning-based predictive modeling of patient outcomes following cardiac surgery. J Thorac Cardiovasc Surg. 2023. https:\/\/doi.org\/10.1016\/j.jtcvs.2023.11.034.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"2016_CR12","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.athoracsur.2018.03.002","volume":"105","author":"DM Shahian","year":"2018","unstructured":"Shahian DM, Jacobs JP, Badhwar V, et al. The Society of Thoracic Surgeons 2018 adult cardiac surgery risk models: part 1-background, design considerations, and model development. Ann Thorac Surg. 2018;105(5):1411\u20138. https:\/\/doi.org\/10.1016\/j.athoracsur.2018.03.002.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"2016_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCOUTCOMES.109.858811","volume":"2","author":"RH Mehta","year":"2009","unstructured":"Mehta RH, Sheng S, O\u2019Brien SM, et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes. 2009;2(6):583\u201390. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.109.858811.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"2016_CR14","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.athoracsur.2018.03.003","volume":"105","author":"SM O'Brien","year":"2018","unstructured":"O\u2019Brien SM, Feng L, He X, et al. The Society of Thoracic Surgeons 2018 adult cardiac surgery risk models: part 2-statistical methods and results. Ann Thorac Surg. 2018;105(5):1419\u201328. https:\/\/doi.org\/10.1016\/j.athoracsur.2018.03.003.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"2016_CR15","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/m14-0698","volume":"162","author":"KGM Moons","year":"2015","unstructured":"Moons KGM, Altman DG, Reitsma JB, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1\u201373. https:\/\/doi.org\/10.7326\/m14-0698.","journal-title":"Ann Intern Med"},{"issue":"9","key":"2016_CR16","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s11606-008-0690-1","volume":"23","author":"G Pernod","year":"2008","unstructured":"Pernod G, Labar\u00e8re J, Yver J, et al. EDUC\u2019AVK: reduction of oral anticoagulant-related adverse events after patient education: a prospective multicenter open randomized study. J Gen Intern Med. 2008;23(9):1441\u20136. https:\/\/doi.org\/10.1007\/s11606-008-0690-1.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"2016_CR17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.ejvs.2008.06.030","volume":"36","author":"D Bergqvist","year":"2008","unstructured":"Bergqvist D, Clement D. Adjudication of end points in studies on substances influencing haemostasis: an example from vascular surgery. Eur J Vasc Endovasc Surg. 2008;36(6):703\u20134. https:\/\/doi.org\/10.1016\/j.ejvs.2008.06.030.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"18","key":"2016_CR18","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/j.scib.2023.08.001","volume":"68","author":"Z-Y An","year":"2023","unstructured":"An Z-Y, Wu Y-J, Hou Y, et al. A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study. Sci Bull. 2023;68(18):2106\u201314. https:\/\/doi.org\/10.1016\/j.scib.2023.08.001.","journal-title":"Sci Bull"},{"issue":"6","key":"2016_CR19","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.thromres.2013.04.033","volume":"131","author":"J Donze","year":"2013","unstructured":"Donze J, Rodondi N, Waeber G, et al. Major bleeding risk in anticoagulated patients receiving concomitant antiplatelet therapy: a prospective study. Thromb Res. 2013;131(6):502\u20137. https:\/\/doi.org\/10.1016\/j.thromres.2013.04.033.","journal-title":"Thromb Res"},{"issue":"18","key":"2016_CR20","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","volume":"383","author":"K Okumura","year":"2020","unstructured":"Okumura K, Akao M, Yoshida T, et al. Low-dose edoxaban in very elderly patients with atrial fibrillation. N Engl J Med. 2020;383(18):1735\u201345. https:\/\/doi.org\/10.1056\/NEJMoa2012883.","journal-title":"N Engl J Med"},{"key":"2016_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/circoutcomes.120.006582","author":"G Marquis-Gravel","year":"2020","unstructured":"Marquis-Gravel G, Neely ML, Valgimigli M, et al. Long-term bleeding risk prediction with dual antiplatelet therapy after acute coronary syndromes treated without revascularization. Circ Cardiovasc Qual Outcomes. 2020. https:\/\/doi.org\/10.1161\/circoutcomes.120.006582.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"2016_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C, International Society on Thrombosis Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692\u20134. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x.","journal-title":"J Thromb Haemost"},{"key":"2016_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1467-9868.2011.00771.x","volume":"73","author":"R Tibshirani","year":"2011","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso: a retrospective. J R Stat Soc Series B Stat Methodol. 2011;73:273\u201382. https:\/\/doi.org\/10.1111\/j.1467-9868.2011.00771.x.","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"2016_CR24","doi-asserted-by":"publisher","first-page":"927312","DOI":"10.3389\/fbinf.2022.927312","volume":"2","author":"N Pudjihartono","year":"2022","unstructured":"Pudjihartono N, Fadason T, Kempa-Liehr AW, et al. A review of feature selection methods for machine learning-based disease risk prediction. Front Bioinform. 2022;2:927312. https:\/\/doi.org\/10.3389\/fbinf.2022.927312.","journal-title":"Front Bioinform"},{"issue":"4","key":"2016_CR25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s11096-024-01724-y","volume":"46","author":"L Chang","year":"2024","unstructured":"Chang L, Hao X, Yu J, et al. Developing a machine learning model for predicting venlafaxine active moiety concentration: a retrospective study using real-world evidence. Int J Clin Pharm. 2024;46(4):899\u2013909. https:\/\/doi.org\/10.1007\/s11096-024-01724-y.","journal-title":"Int J Clin Pharm"},{"key":"2016_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1503713","author":"Y Hua","year":"2024","unstructured":"Hua Y, Li N, Lao J, et al. Machine learning models for coagulation dysfunction risk in inpatients administered \u03b2-lactam antibiotics. Front Pharmacol. 2024. https:\/\/doi.org\/10.3389\/fphar.2024.1503713.","journal-title":"Front Pharmacol"},{"key":"2016_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46663-4","author":"RL Nielsen","year":"2024","unstructured":"Nielsen RL, Monfeuga T, Kitchen RR, et al. Data-driven identification of predictive risk biomarkers for subgroups of osteoarthritis using interpretable machine learning. Nat Commun. 2024. https:\/\/doi.org\/10.1038\/s41467-024-46663-4.","journal-title":"Nat Commun"},{"key":"2016_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-024-01818-7","author":"L Pan","year":"2024","unstructured":"Pan L, Mu L, Lei H, et al. Predicting survival benefits of immune checkpoint inhibitor therapy in lung cancer patients: a machine learning approach using real-world data. Int J Clin Pharm. 2024. https:\/\/doi.org\/10.1007\/s11096-024-01818-7.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"2016_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11096-023-01638-1","volume":"46","author":"L-P Ding","year":"2024","unstructured":"Ding L-P, Li P, Yang L-R, et al. A novel machine learning model to predict high on-treatment platelet reactivity on clopidogrel in Asian patients after percutaneous coronary intervention. Int J Clin Pharm. 2024;46(1):90\u2013100. https:\/\/doi.org\/10.1007\/s11096-023-01638-1.","journal-title":"Int J Clin Pharm"},{"key":"2016_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1538074","author":"P Zhang","year":"2025","unstructured":"Zhang P, Chen Q, Lao J, et al. Machine learning modeling for the risk of acute kidney injury in inpatients receiving amikacin and etimicin. Front Pharmacol. 2025. https:\/\/doi.org\/10.3389\/fphar.2025.1538074.","journal-title":"Front Pharmacol"},{"key":"2016_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.thromres.2016.10.027","volume":"151","author":"N Zenati","year":"2017","unstructured":"Zenati N, Gaboreau Y, Provencher CB, et al. Anaemia as an independent key risk factor for major haemorrhage in patients treated with vitamin K antagonists: Results of the SCORE prospective cohort. Thromb Res. 2017;151:83\u20138. https:\/\/doi.org\/10.1016\/j.thromres.2016.10.027.","journal-title":"Thromb Res"},{"issue":"12","key":"2016_CR32","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.amjcard.2014.09.023","volume":"114","author":"V Kunadian","year":"2014","unstructured":"Kunadian V, Mehran R, Lincoff AM, et al. Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the acute catheterization and urgent intervention triage strategy trial). Am J Cardiol. 2014;114(12):1823\u20139. https:\/\/doi.org\/10.1016\/j.amjcard.2014.09.023.","journal-title":"Am J Cardiol"},{"issue":"4","key":"2016_CR33","doi-asserted-by":"publisher","first-page":"e007133","DOI":"10.1161\/circinterventions.118.007133","volume":"12","author":"M Faggioni","year":"2019","unstructured":"Faggioni M, Baber U, Sartori S, et al. Influence of baseline anemia on dual antiplatelet therapy cessation and risk of adverse events after percutaneous coronary intervention. Circ Cardiovasc Interv. 2019;12(4):e007133. https:\/\/doi.org\/10.1161\/circinterventions.118.007133.","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"2016_CR34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/apt.18139","volume":"60","author":"N Forbes","year":"2024","unstructured":"Forbes N, Yi Q, Moayyedi P, et al. Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low-dose rivaroxaban, or the combination: secondary analysis of the COMPASS randomised controlled trial. Aliment Pharmacol Ther. 2024;60(6):737\u201348. https:\/\/doi.org\/10.1111\/apt.18139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"15","key":"2016_CR35","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/heartjnl-2016-310090","volume":"103","author":"J Alfredsson","year":"2017","unstructured":"Alfredsson J, Neely B, Neely ML, et al. Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes. Heart. 2017;103(15):1168\u201376. https:\/\/doi.org\/10.1136\/heartjnl-2016-310090.","journal-title":"Heart"},{"key":"2016_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105005","author":"H Liu","year":"2020","unstructured":"Liu H, Xu Q, Li A. Nomogram for predicting delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage in the Chinese population. J Stroke Cerebrovasc Dis. 2020. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105005.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"2016_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"GYH Lip","year":"2011","unstructured":"Lip GYH, Frison L, Halperin JL, et al. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation the HAS-BLED (Hypertension, Abnormal Renal\/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs\/Alcohol Concomitantly) score. J Am Coll Cardiol. 2011;57(2):173\u201380. https:\/\/doi.org\/10.1016\/j.jacc.2010.09.024.","journal-title":"J Am Coll Cardiol"},{"key":"2016_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2021.02.096","author":"I Sultan","year":"2023","unstructured":"Sultan I, Bianco V, Aranda-Michel E, et al. The use of blood and blood products in aortic surgery is associated with adverse outcomes. J Thorac Cardiovasc Surg. 2023. https:\/\/doi.org\/10.1016\/j.jtcvs.2021.02.096.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2016_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.52148","author":"Y Lu","year":"2024","unstructured":"Lu Y, Zhang Q, Jiang J, et al. An externally validated prognostic model for critically ill patients with traumatic brain injury. Ann Clin Transl Neurol. 2024. https:\/\/doi.org\/10.1002\/acn3.52148.","journal-title":"Ann Clin Transl Neurol"},{"key":"2016_CR40","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.4914","author":"EJ Emanuel","year":"2019","unstructured":"Emanuel EJ, Wachter RM. Artificial intelligence in health care. JAMA. 2019. https:\/\/doi.org\/10.1001\/jama.2019.4914.","journal-title":"JAMA"},{"issue":"14","key":"2016_CR41","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1001\/jama.2019.10306","volume":"322","author":"NH Shah","year":"2019","unstructured":"Shah NH, Milstein A, Bagley PSC. Making machine learning models clinically useful. JAMA. 2019;322(14):1351\u20132. https:\/\/doi.org\/10.1001\/jama.2019.10306.","journal-title":"JAMA"},{"issue":"1","key":"2016_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.7326\/m19-2548","volume":"172","author":"F Wang","year":"2019","unstructured":"Wang F, Kaushal R, Khullar D. Should health care demand interpretable artificial intelligence or accept \u201cblack box\u201d medicine? Ann Intern Med. 2019;172(1):59\u201360. https:\/\/doi.org\/10.7326\/m19-2548.","journal-title":"Ann Intern Med"},{"issue":"7","key":"2016_CR43","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.cell.2018.05.015","volume":"173","author":"DM Camacho","year":"2018","unstructured":"Camacho DM, Collins KM, Powers RK, et al. Next-generation machine learning for biological networks. Cell. 2018;173(7):1581\u201392. https:\/\/doi.org\/10.1016\/j.cell.2018.05.015.","journal-title":"Cell"},{"issue":"5","key":"2016_CR44","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1016\/s1470-2045(19)30149-4","volume":"20","author":"KY Ngiam","year":"2019","unstructured":"Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. Lancet Oncol. 2019;20(5):e262\u201373. https:\/\/doi.org\/10.1016\/s1470-2045(19)30149-4.","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02016-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-02016-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02016-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:05:15Z","timestamp":1773662715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-02016-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["2016"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-02016-9","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of Nanjing Drum Tower Hospital (Approval No. 2024-301-01; approval data May 21st, 2024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}